Human Longevity Pledges $1Million to Fight Ovarian Cancer
July 18, 2025
New pledge underscores confidence in early detection, supported by the Avantect Liquid Biopsy and HLI’s Executive Health Program Human Longevity, Inc., a global leader in precision medicine